OTC · Shell Companies

Myrexis, Inc. (MYRX) Stock

$0.01 +775.00% OTC: MYRX Financial Services

Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector.

Valuation

MetricValue
Price$0.01
Market Cap$241353
P/E Ratio-0.02
P/B Ratio0.18
P/S Ratio0.00
EPS (TTM)$-0.39
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.67%
ROA-939.45%
ROCE-1200.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio16.72

Annual Financials (USD)

Metric20082009201020112012
Revenue$5.0M$0$0$0$0
Operating Profit$-58.0M$-48.0M$-39.0M$-32.0M$-12.0M
Net Profit$-58.0M$-47.0M$-39.0M$-31.0M$-12.0M
EPS$-2.42$-1.91$-1.52$-1.18$-0.39
Op Margin-1065.5%-53462.2%-21270.3%——

Balance Sheet (USD)

Metric20082009201020112012
Total Assets$194.0M$154.0M$121.0M$92.0M$1.0M
Total Liabilities$5.0M$4.0M$3.0M$2.0M$0
Cash$128.0M$36.0M$19.0M$20.0M$1.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20082009201020112012
Operating Cash Flow$-61.0M$-40.0M$-33.0M$-28.0M$-13.0M
Investing Cash Flow$-7.0M$-57.0M$15.0M$27.0M$71.0M
Financing Cash Flow$194.0M$0$0$-79.0M$-77.0M
Net Cash Flow$128.0M$-92.0M$-17.0M$1.0M$-19.0M
Free Cash Flow$-61.0M$-43.0M$-34.0M$-28.0M$-13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.07
FCF Yield-5374.70%
Quick Ratio16.72
Interest Coverage0.00
Return 1Y3400.00%
Return 3Y2233.33%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held1.26%
Institutions Float Held1.26%
Institutional HolderSharesReport Date
First Command Advisory Services, Inc.42026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPTAll American Pet Company, Inc. $0.00 — -0.02 $172870 0.00%
ALDAAtlantica, Inc. $0.05 +0.00% -0.28 $122930 0.00%
CDSGChina Dongsheng International, Inc. $0.00 — 3.80 $59937 0.00%
CNHCChina Health Management Corp. $0.00 — 8.75 $284011 0.00%
JADAJade Art Group Inc. $0.00 — -0.03 $8009 0.00%

About Myrexis, Inc.

Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New York.

Myrexis, Inc. is headquartered in US.

Myrexis, Inc. (MYRX) stock trades at $0.01 with a market capitalization of $241353. The stock is valued at a price-to-earnings (P/E) ratio of -0.02, price-to-book of 0.18, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades at its 52-week high.

On profitability, Myrexis, Inc. generates a return on equity (ROE) of -25.67%, return on capital employed of -1200.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.myrexis.com

Related Financial Services Stocks

BRK.A Insurance - Diversified $733370.00 +0.00% BRK.B FIRE, MARINE & CASUALTY INSURANCE $482.70 +0.00% JPM Banks - Diversified $357.52 +0.34% V Financial - Credit Services $362.50 -2.15% MA Financial - Credit Services $562.95 -2.26% BAC Banks - Diversified $63.17 +0.27% HSBC Banks - Diversified $102.60 -1.06% MS Financial - Capital Markets $203.19 -3.97% GS Financial - Capital Markets $980.75 -5.09% RY Banks - Diversified $206.45 -2.79% WFC Banks - Diversified $83.87 -3.45% MUFG Banks - Diversified $21.94 -2.18%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)Exxon Mobil (XOM)

Screens featuring this stock

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksAll stock screens
Run Stock Screener Investing Guides